4/22
05:42 pm
gbio
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting [Yahoo! Finance]
High
Report
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting [Yahoo! Finance]
4/22
05:31 pm
gbio
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
High
Report
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
4/10
08:05 am
gbio
Generation Bio Co. (NASDAQ: GBIO) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Medium
Report
Generation Bio Co. (NASDAQ: GBIO) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
4/2
06:59 am
gbio
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
3/8
04:50 am
gbio
Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes [Yahoo! Finance]
High
Report
Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes [Yahoo! Finance]
3/7
08:25 am
gbio
Generation Bio Co. (NASDAQ: GBIO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Medium
Report
Generation Bio Co. (NASDAQ: GBIO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
3/7
08:01 am
gbio
Generation Bio Co. (NASDAQ: GBIO) had its price target lowered by analysts at Needham & Company LLC from $14.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Generation Bio Co. (NASDAQ: GBIO) had its price target lowered by analysts at Needham & Company LLC from $14.00 to $10.00. They now have a "buy" rating on the stock.
3/6
04:22 pm
gbio
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Low
Report
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
3/6
04:20 pm
gbio
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
High
Report
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
2/27
07:12 am
gbio
Generation Bio to Present at the 2024 TD Cowen Health Care Conference [Yahoo! Finance]
High
Report
Generation Bio to Present at the 2024 TD Cowen Health Care Conference [Yahoo! Finance]
2/27
06:59 am
gbio
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
High
Report
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
2/25
07:34 am
gbio
Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Neutral
Report
Generation Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]